Phenotype
|
Fish
|
Conditions
|
Figures
|
pharyngeal arch 3-7 prdm1a expression increased distribution, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
pharyngeal arch cartilage col2a1a expression decreased distribution, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1
from Shull et al., 2020
|
chondrocranium chondrocyte disorganized, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1
from Shull et al., 2022
|
opercle decreased size, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1
from Shull et al., 2020
|
chondrocranium cartilage hypoplastic, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1
from Shull et al., 2022
|
cranial cartilage col2a1a expression decreased distribution, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1
from Shull et al., 2020
|
ceratobranchial 5 bone decreased size, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1
from Shull et al., 2020
|
chondrocranium mediolateral intercalation normal process quality, ameliorated
|
mecomco1005/co1005
|
chemical treatment by environment: IWR-1-endo
|
Fig. 6
from Shull et al., 2022
|
chondrocranium cartilage cartilage morphogenesis decreased process quality, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1
from Shull et al., 2022
|
Meckel's cartilage hypoplastic, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1
from Shull et al., 2020
|
trabecula cranii decreased distance trabecula cranii, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1
from Shull et al., 2020
|
pectoral fin bud prdm1a expression increased distribution, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
pharyngeal arch runx2b expression decreased distribution, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1
from Shull et al., 2020
|
Meckel's cartilage decreased distance palatoquadrate cartilage, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1
from Shull et al., 2020
|
opercle bone mineralization decreased occurrence, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1
from Shull et al., 2020
|
cranium runx2b expression decreased distribution, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1
from Shull et al., 2020
|
eye prdm1a expression increased distribution, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
head prdm1a expression increased amount, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
ceratobranchial 5 bone bone mineralization decreased occurrence, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1
from Shull et al., 2020
|
head prdm16 expression increased amount, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
hatching gland prdm1a expression increased distribution, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
chondrocranium cartilage hypoplastic, abnormal
|
mecomco1005/co1005
|
chemical treatment by environment: IWR-1-endo
|
Fig. 6
from Shull et al., 2022
|
chondrocranium mediolateral intercalation decreased process quality, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1 ,
Fig. 6
from Shull et al., 2022
|
ceratobranchial cartilage hypoplastic, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1
from Shull et al., 2020
|
palatoquadrate cartilage hypoplastic, abnormal
|
mecomco1005/co1005
|
standard conditions
|
Fig. 1
from Shull et al., 2020
|
Wnt signalosome assembly increased rate, abnormal
|
mecomco1005/co1005; ba2Tg/ba2Tg
|
standard conditions
|
Fig. 3
from Shull et al., 2022
|
cranial neural crest cell fosab expression increased amount, abnormal
|
mecomco1005/co1005; ba2Tg/ba2Tg
|
standard conditions
|
Fig. 3
from Shull et al., 2022
|
cranial neural crest apc expression increased amount, abnormal
|
mecomco1005/co1005; ba2Tg/ba2Tg
|
standard conditions
|
Fig. 3
from Shull et al., 2022
|
cranial neural crest cell jun expression increased amount, abnormal
|
mecomco1005/co1005; ba2Tg/ba2Tg
|
standard conditions
|
Fig. 3
from Shull et al., 2022
|
cranial neural crest cell dvl3a expression increased amount, abnormal
|
mecomco1005/co1005; ba2Tg/ba2Tg
|
standard conditions
|
Fig. 3
from Shull et al., 2022
|
cranial neural crest chromatin remodeling decreased process quality, abnormal
|
mecomco1005/co1005; ba2Tg/ba2Tg
|
standard conditions
|
Fig. 5
from Shull et al., 2022
|
cranial neural crest cell tcf7 expression increased amount, abnormal
|
mecomco1005/co1005; ba2Tg/ba2Tg
|
standard conditions
|
Fig. 3
from Shull et al., 2022
|
cranial neural crest cell fzd3b expression increased amount, abnormal
|
mecomco1005/co1005; ba2Tg/ba2Tg
|
standard conditions
|
Fig. 3
from Shull et al., 2022
|
cranial neural crest cell bcl9 expression increased amount, abnormal
|
mecomco1005/co1005; ba2Tg/ba2Tg
|
standard conditions
|
Fig. 3
from Shull et al., 2022
|
chondrocyte nucleus Ab5-ctnnb1 labeling increased amount, abnormal
|
mecomco1005/co1005; ba2Tg/ba2Tg
|
standard conditions
|
Fig. 4
from Shull et al., 2022
|
cranial neural crest cell pygo1 expression increased amount, abnormal
|
mecomco1005/co1005; ba2Tg/ba2Tg
|
standard conditions
|
Fig. 3
from Shull et al., 2022
|
cranial neural crest cell smarca4a expression increased amount, abnormal
|
mecomco1005/co1005; ba2Tg/ba2Tg
|
standard conditions
|
Fig. 3
from Shull et al., 2022
|
cranial neural crest cell ctnnb1 expression increased amount, abnormal
|
mecomco1005/co1005; ba2Tg/ba2Tg
|
standard conditions
|
Fig. 3
from Shull et al., 2022
|
cranial neural crest cell pygo2 expression increased amount, abnormal
|
mecomco1005/co1005; ba2Tg/ba2Tg
|
standard conditions
|
Fig. 3
from Shull et al., 2022
|
cranial neural crest cell lef1 expression increased amount, abnormal
|
mecomco1005/co1005; ba2Tg/ba2Tg
|
standard conditions
|
Fig. 3
from Shull et al., 2022
|
pharyngeal arch Wnt signalosome mCherry expression increased amount, abnormal
|
mecomco1005/co1005; ia5Tg/ia5Tg; y1Tg/y1Tg
|
standard conditions
|
Fig. 4
from Shull et al., 2022
|
chondrocranium mediolateral intercalation normal process quality, ameliorated
|
prdm16co1006/co1006; mecomco1005/co1005
|
standard conditions
|
Fig. 6
from Shull et al., 2022
|
chondrocranium cartilage normal amount, ameliorated
|
prdm16co1006/co1006; mecomco1005/co1005
|
standard conditions
|
Fig. 6
from Shull et al., 2022
|
palatoquadrate cartilage hypoplastic, abnormal
|
prdm16co1006/+; prdm1am805/+; mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
Meckel's cartilage hypoplastic, abnormal
|
prdm16co1006/+; prdm1am805/+; mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
Meckel's cartilage decreased distance palatoquadrate cartilage, abnormal
|
prdm16co1006/+; prdm1am805/+; mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
ceratobranchial cartilage aplastic, abnormal
|
prdm16co1006/+; prdm1am805/m805; mecomco1005/+
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
palatoquadrate cartilage hypoplastic, abnormal
|
prdm16co1006/+; prdm1am805/m805; mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
ethmoid cartilage split, abnormal
|
prdm16co1006/+; prdm1am805/m805; mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
Meckel's cartilage hypoplastic, abnormal
|
prdm16co1006/+; prdm1am805/m805; mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
ceratobranchial cartilage aplastic, abnormal
|
prdm16co1006/+; prdm1am805/m805; mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
Meckel's cartilage decreased distance palatoquadrate cartilage, abnormal
|
prdm16co1006/co1006; prdm1am805/+; mecomco1005/+
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
Meckel's cartilage aplastic/hypoplastic, abnormal
|
prdm16co1006/co1006; prdm1am805/+; mecomco1005/+
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
Meckel's cartilage decreased distance palatoquadrate cartilage, abnormal
|
prdm16co1006/co1006; prdm1am805/+; mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
Meckel's cartilage aplastic/hypoplastic, abnormal
|
prdm16co1006/co1006; prdm1am805/+; mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
ethmoid cartilage split, abnormal
|
prdm16co1006/co1006; prdm1am805/m805; mecomco1005/+
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
Meckel's cartilage decreased distance palatoquadrate cartilage, abnormal
|
prdm16co1006/co1006; prdm1am805/m805; mecomco1005/+
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
ceratobranchial cartilage aplastic, abnormal
|
prdm16co1006/co1006; prdm1am805/m805; mecomco1005/+
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
Meckel's cartilage aplastic/hypoplastic, abnormal
|
prdm16co1006/co1006; prdm1am805/m805; mecomco1005/+
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
palatoquadrate cartilage hypoplastic, abnormal
|
prdm16co1006/co1006; prdm1am805/m805; mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
ethmoid cartilage split, abnormal
|
prdm16co1006/co1006; prdm1am805/m805; mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
Meckel's cartilage hypoplastic, abnormal
|
prdm16co1006/co1006; prdm1am805/m805; mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
Meckel's cartilage decreased distance palatoquadrate cartilage, abnormal
|
prdm16co1006/co1006; prdm1am805/m805; mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
ceratobranchial cartilage aplastic, abnormal
|
prdm16co1006/co1006; prdm1am805/m805; mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|
Meckel's cartilage aplastic/hypoplastic, abnormal
|
prdm16co1006/co1006; prdm1am805/m805; mecomco1005/co1005
|
standard conditions
|
Fig. 3
from Shull et al., 2020
|